Pradaxa advice unchanged: TGA
5th August 2014
Australians using controversial anticoagulant Pradaxa (dabigatran) are being advised to continue taking the drug, despite recent reports questioning its safety profile.
Log In
Welcome to AusDoc.Plus, the new home of Australian Doctor, Medical Observer, 6minutes and How to Treat. You can use your existing login credentials for any of these sites to gain entry.
Not a member?
Join AusDoc.PLUS
Register
To ensure you get the right membership, please select your vocation: